Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bristol agrees to ADAP discounts

Executive Summary

Bristol agrees to provide additional aid to state AIDS Drug Assistance programs by offering them "its entire portfolio of HIV medications at a reduced cost" through March 31, 2005. Bristol is the last of eight HIV drug manufacturers to reach an agreement with the ADAP coalition (1"The Pink Sheet" July 14, 2003, In Brief)....1

You may also be interested in...

ADAP/manufacturer agreements

Pfizer, GlaxoSmithKline and Boehringer-Ingelheim agree to provide additional aid to AIDS Drug Assistance Programs. GSK will offer a "$20 mil. financial aid package" to ADAPs to help cut waiting lists and avoid program restrictions, company says. Pfizer is offering its antiretroviral drugs Viracept and Rescriptor "either free or at greatly discounted prices" and will "maintain price neutrality" on its new 625 mg Viracept formulation compared to older formulations, Pfizer says. Negotiations with Bristol-Myers Squibb continue (1"The Pink Sheet" May 19, 2003, In Brief)...

Pulling In 10 Different Directions – The Challenge Of Harmonizing Asia’s VMS Market

A lack of regulatory harmonization for dietary supplements in Asia is a big challenge facing companies operating in the region, according to experts from the Asia Regulatory Professionals Association. The ARPA is looking to start a conversation on the issue which the association hopes will lead to regulatory change.

China CSCO Hails Rising Liver Cancer Innovation Ready To Take On World

The Chinese Society of Clinical Oncology (CSCO) annual meeting, against the background of the global pandemic, has one clear message that local researchers and players are pressing ahead to take a leadership role in cutting-edge cancer research globally.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts